Albany, NY -- (SBWIRE) -- 01/09/2014 -- The Personalized Medicine in Oncology Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the personalized medicine in oncology partnering agreements entered into by the worlds leading healthcare companies.

The report provides a detailed understanding and analysis of how and why companies enter personalized medicine in oncology partnering deals. The majority of deals are discovery stage whereby the licensee obtains a right or an option right to license the licensors personalized medicine technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Browse Full Report with TOC: http://www.marketresearchreports.biz/analysis-details/personalized-medicine-in-oncology-partnering-terms-and-agreements

The initial chapters of this report provide an orientation of personalized medicine in oncology dealmaking and business activities.

Chapter 1 provides an introduction to the report, whilst

chapter 2 provides an overview of the trends in personalized medicine in oncology dealmaking since 2007, including details of average headline, upfront, milestone and royalty terms.It also provides the number of deals entered by top 50 big pharma and most active dealmakers in personalized medicine in oncology partnering. The chapter also includes examples case studies of recent deals in personalized medicine in oncology partnering.

Chapter 3 provides a review of the leading personalized medicine in oncology deals since 2007. Deals are listed by headline value signed by all biopharma companies. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 4 provides a comprehensive and detailed review of personalized medicine in oncology partnering deals signed and announced since January 2007. The chapter is organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), specific therapy focus and specific technology focus. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand. The report also includes adjuvant deals and alliances.

To Get Download Full Report with TOC: http://www.marketresearchreports.biz/sample/sample/182391

Report scope

Personalized Medicine in Oncology Partnering Terms and Agreements is intended to provide the reader with an in-depth understanding of the personalized medicine in oncology trends and structure of deals entered into by leading companies worldwide.

Personalized Medicine in Oncology Partnering Terms and Agreements includes:

- Trends in personalized medicine in oncology dealmaking in the biopharma industry since 2007
- Analysis of personalized medicine in oncology deal structure
- Case studies of real-life personalized medicine in oncology deals
- Access to over 600 personalized medicine in oncology deals
- The leading personalized medicine in oncology deals by value since 2007

In Personalized Medicine in Oncology Partnering Terms and Agreements , the available contracts are listed by:

- Headline value
- Stage of development at signing
- Deal component type
- Specific therapy target

Each deal title links via Weblink to online deal records of actual personalized medicine in oncology partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners.

To Read Complete Report with TOC: http://www.marketresearchreports.biz/analysis/182391

Table of Content:

Executive Summary

Chapter 1 – Introduction

Chapter 2 – Trends in personalized medicine in oncology dealmaking
2.1. Introduction
2.2. Personalized medicine in oncology partnering over the years
2.2.1 Biomarker in oncology partnering over the years
2.2.2 Companion diagnostic in oncology partnering over the years
2.2.3 Pharmacogenomics in oncology partnering over the years
2.3. Big pharma personalized medicine in oncology dealmaking activity

Contact US:
Office: United States
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States

Toll Free: 866-997-4948
Tel: +1-518-618-1030
E: sales@marketresearchreports.biz

Blog: http://chinamarketreports.blogspot.com/

Site: http://www.marketresearchreports.biz/

Browse Full Report with TOC: http://www.marketresearchreports.biz/analysis-details/personalized-medicine-in-oncology-partnering-terms-and-agreements